Conference
Effect of an Anti-M1 Prime Monoclonal Antibody, MEMP1972A, in a Phase II Proof-Of-Activity Allergen Challenge Study in Patients with Mild Asthma
Authors
Gauvreau G; Boulet L-P; Cockcroft DW; Davis B; Fitzgerald MJ; Leigh R; Dahlen B; Mayers I; Scheerens H; Maciuca R
Volume
185
Pagination
pp. a6793-a6793
Publisher
Oxford University Press (OUP)
Publication Date
May 1, 2012
DOI
10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6793
Name of conference
B37. NEW INSIGHTS INTO ASTHMA AND COPD TREATMENT
Conference proceedings
American Journal of Respiratory and Critical Care Medicine
Issue
Supplement_1
ISSN
1073-449X
